<?xml version="1.0" encoding="utf-8" standalone="no"?>
<key-projects>
  <projects>
    <title>CBER Participation in CBER Liaison and Roundtable Meetings with Industry</title>
    <description>CBER holds recurring liaison and roundtable meetings with outside organization to provide an opportunity to discuss topics of mutual interest and for outside concerns to be expressed, as well as to provide information on CBER’s operations. OCOD serves in a coordinating role by scheduling and documenting liaison and roundtable meetings with industry, trade associations and consumer organizations. This key project will be to evaluate these meetings and determine what, if any, changes need to be made to the program.</description>
    <dictionary></dictionary>
    <outcome></outcome>
    <accomplishment></accomplishment>
    <free-text></free-text>
    <table>
      <title></title>
      <free-text-table></free-text-table>
      <overall-status>
        <briefing>ON TRACK</briefing>
        <prior-briefing>ON TRACK</prior-briefing>
      </overall-status>
      <row>
        <type></type>
        <milestone-description>A. Contact CBER Program Offices to identify the organizations for liaison and roundtable meetings each plans to support during the calendar year.</milestone-description>
        <milestone-date>2/15/2012</milestone-date>
        <milestone-status>Completed</milestone-status>
        <milestone-completion-date>1/15/2012</milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>B. Develop survey to solicit feedback from CBER Program Offices regarding the liaison/roundtable meeting program. </milestone-description>
        <milestone-date>9/15/2012</milestone-date>
        <milestone-status>Completed</milestone-status>
        <milestone-completion-date>9/15/2012</milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>C. Processing of liaison meeting requests: Capture the number of internal pre-meetings and external liaison/roundtable meetings scheduled during the quarters: 4/5/2012 (1), 7/5/2012, 10/5/2012, and 1/5/2013</milestone-description>
        <milestone-date>1/5/2013</milestone-date>
        <milestone-status>On Track</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>D. Upon completion of liaison/roundtable meetings for the calendar year, administer survey to CBER Program Offices regarding resources spent, time, value of meeting discussions.</milestone-description>
        <milestone-date>1/15/2013</milestone-date>
        <milestone-status>On Track</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>E. Evaluate survey results and prepare report for CBER Office Directors with recommendations for potential changes to program.</milestone-description>
        <milestone-date>3/1/2013</milestone-date>
        <milestone-status>Not Yet Started</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>F. Program or SOPP revisions based on evaluations results.</milestone-description>
        <milestone-date>5/1/2013</milestone-date>
        <milestone-status>Not Yet Started</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <footnotes>
        <note>(1) There have been 3 internal pre-meetings and 0 external liaison/roundtable meetings during the first quarter of calendar year 2012.</note>
      </footnotes>
    </table>
  </projects>
  <glossary>
    <word>
      <text>Molecular Epidemiology</text>
      <definition>Molecular epidemiology is a branch of medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations.</definition>
    </word>
  </glossary>
  <related-links>
    <link>
      <url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206804.htm#OCOD_KP</url>
      <text>FDA-TRACK CBER Cross Management Support Offices Dashboard</text>
    </link>
  </related-links>
</key-projects>਍††਍਍਍਍਍਍਍